Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/Evidence/557374 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: Health_related_quality_of_life_Comparator_Evidence_from_MAGICapp_109587 | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#557374, outcomeId: 109587, picoId: 85798, sectionId: 73215, OID:2.16.840.1.113883.4.642.40.44.22.135 | |||||
Usage: Evidence Communication: ComparatorOnlyEvidence |
|||||
Copyright/Legal: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse). |
|||||
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
version: 2; Last updated: 2026-08-06 17:15:59+0000
Profile: ComparatorOnlyEvidence
ArtifactPublicationStatus: Active
identifier: FEvIR Object Identifier/557374, outcomeId/109587, picoId/85798, sectionId/73215, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.22.135
version: 1.0.0-ballot3
name: Health_related_quality_of_life_Comparator_Evidence_from_MAGICapp_109587
title: MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in GLP-1 RA Group in Adults with type 2 diabetes
citeAs:
MAGIC-derived ComparatorOnlyEvidence: Health-related quality of life in GLP-1 RA Group in Adults with type 2 diabetes [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 557374. Revised 2026-08-06. Available at: https://fevir.net/resources/Evidence/557374. Computable resource at: https://fevir.net/resources/Evidence/557374#json.
status: Active
date: 2026-11-05 14:34:28+0000
author: Computable Publishing®: MAGIC-to-FEvIR Converter:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
| Code | Value[x] |
| Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication) | ComparatorOnlyEvidence |
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
| Type | Target[x] |
| Part Of | MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report) |
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
variableDefinition
description:
Adults with type 2 diabetes -- GLP-1 RA
variableRole: Population
variableDefinition
description:
Health-related quality of life
variableRole: Outcome
observed: Health-related quality of life
synthesisType: NOTSET
studyDesign: PRIMARY_STUDY
statistic
description:
MEAN 51.84
statisticType: mean
quantity: 51.84
AttributeEstimates
Description Type Quantity SD 7.0
SD 7